6.65
price up icon3.91%   0.25
after-market Handel nachbörslich: 6.66 0.010 +0.15%
loading

Finanzdaten der Capricor Therapeutics Inc-Aktie (CAPR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 11.13 2.2616 3.9714
Operating Expenses
10.95%
27.72
24.98 18.83 15.27 15.56
Operating Income/Loss
10.95%
-27.72
-24.98 -7.6978 -13.01 -11.59
Nonoperating Income/Loss
205.80%
1.8083
0.5914 0.5812 0.4532 0.5914
Income/Loss From Continuing Operations Before Tax
6.23%
-25.91
-24.39 -7.1166 2.2616 -11.00
Income/Loss From Continuing Operations After Tax
6.23%
-25.91
-24.39 -7.1166 -12.56 -11.00
Net Income/Loss
6.23%
-25.91
-24.39 -7.1166 -12.56 -11.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.16%
45.71
45.64 3.1194 33.09 31.84
Diluted Average Shares
0.16%
45.71
45.64 3.1194 33.09 31.84
Basic Earnings Per Share
7.55%
-0.57
-0.53 -0.11 -0.38 -0.35
Diluted Earnings Per Share
7.55%
-0.57
-0.53 -0.11 -0.38 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.24
price up icon 1.43%
$86.53
price up icon 0.62%
$28.28
price up icon 0.86%
$96.22
price down icon 0.09%
$144.76
price down icon 0.75%
biotechnology ONC
$334.40
price down icon 2.48%
Kapitalisierung:     |  Volumen (24h):